Company Filing History:
Years Active: 1999-2006
Title: Kenneth L Duchin: Innovator in Pharmaceutical Bioavailability
Introduction
Kenneth L Duchin is a notable inventor based in Fort Lauderdale, FL (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 8 patents, focusing on methods and compositions that enhance the oral bioavailability of pharmaceutical agents, particularly those used in cancer treatment.
Latest Patents
One of his latest patents is titled "Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents." This invention addresses the challenge of poor oral bioavailability of antitumor agents such as paclitaxel, docetaxel, and etoposide. The method involves the co-administration of a target agent with an oral bioavailability-enhancing agent, such as cyclosporin A, to improve therapeutic outcomes. Another significant patent is "Method and compositions for administering taxanes orally to human patients." This patent outlines a method for administering taxane antineoplastic agents, which traditionally have poor oral bioavailability, to achieve therapeutic blood levels in patients suffering from taxane-responsive diseases.
Career Highlights
Kenneth L Duchin has made significant strides in the pharmaceutical industry, particularly through his work at Baker Norton Pharmaceuticals, Inc. His innovative approaches have contributed to advancements in cancer treatment, providing new avenues for effective drug administration.
Collaborations
Throughout his career, Duchin has collaborated with esteemed colleagues such as Samuel Broder and Sami Selim, further enhancing the impact of his work in the pharmaceutical field.
Conclusion
Kenneth L Duchin's contributions to pharmaceutical innovations, particularly in enhancing the oral bioavailability of critical cancer treatments, underscore his role as a leading inventor in the industry. His work continues to influence the development of effective therapeutic strategies for patients.